Erectile Dysfunction Market Size to Reach Revenues of USD 4.7 Billion by 2026 - Arizton

CHICAGO, Feb. 9, 2021 /PRNewswire/ -- The global erectile dysfunction market is expected to retract at a CAGR of around (0.4%) during the period 2020-2026.

Key Highlights Offered in the Report:

    1. ED is the most prevalent male sexual disorder globally. Multiple
       therapeutic and device treatment modalities are currently available for
       the management of the disease. However, the market is likely to witness a
       negative growth rate of around (-0.4%) due to drastic decline in revenues
       of popular branded drugs such as Viagra and Cialis.
    2. Oral therapies, especially Viagra, Cialis, and Levitra, dominated the
       market with around USD 3.8 billion revenue in 2020. All the three
       flagship oral ED therapies will lose patent during the forecast period,
       thereby providing space for the entry of low-cost generics.
    3. Compared to therapeutics, ED devices market is likely to grow at a faster
       rate and witness an absolute growth of around 22% during the forecast
    4. The penile implants segment accounted for the largest share of around 49%
       in 2020 in the global ED devices market. The major factor behind this
       largest share is the permanent cure for the disease coupled with around
       90% satisfaction among patients using penile implants.
    5. Vendors in the market should focus on innovations in advanced drug
       formulations as well as technologically advanced devices, which can
       attain high acceptance among the patient population with potential to
       cure the disease.
    6. The topical drug formulation is likely to witness the highest absolute
       growth of around 27% due to its easy accessibility and improved action
       with minimal side effects during the forecast period.

Key Offerings:

    --  Market Size & Forecast by Revenue | 2020-2026
    --  Market Dynamics - Leading trends, growth drivers, restraints, and
        investment opportunities
    --  Market Segmentation - A detailed analysis by product, drugs, devices,
        distribution, and geography
    --  Competitive Landscape - 9 key vendors and 37 other vendors

Get your sample today!

Erectile Dysfunction Market - Segmentation

    --  Erectile Dysfunction (ED) drugs occupy the major share of the ED drugs
        market due to physicians' high recommendations and high efficiency. The
        advent of topical formulations and innovations in minimal invasive
        penile suppositories is likely to boost the market during the forecast
    --  Oral drugs are found to be more effective and safe drugs and are
        considered first-line therapy in the treatment of ED. Hence, these drugs
        account for over 94% share of the market. Innovations in oral PDE-5
        inhibitors include novel oral transmucosal drug delivery through oral
        dispersive tablets, or oral dispersible film is expected to boost market
        growth during the forecast period.
    --  Vacuum constriction devices (VCD) accounted for over 39% of the global
        erectile dysfunction devices market in 2020. These devices are
        experiencing growth owing to their non-invasive nature and high patient
        satisfaction. Over 90% of the patient population experienced successful
        erectile function with VCD, thereby boosting the market growth. North
        America dominates ED devices' usage due to the high accessibility to
        healthcare infrastructure, high prevalence of ED disorder, and
        increasing chronic health disorders.

Erectile Dysfunction Market by Products

    --  Drugs
    --  Devices

Erectile Dysfunction Market by Drugs

    --  Route of Administration
        --  Oral Drugs
        --  Topical Formulation
        --  Penile Injections & Suppositories
    --  Distribution
        --  Hospital Pharmacies
        --  Offline Retail Pharmacies
        --  Online Channels

Erectile Dysfunction Market by Devices

    --  Penile Implants
    --  Vacuum Therapy Devices
    --  Shockwave Therapy
    --  Others

Erectile Dysfunction Market - Dynamics

Vendors are focusing on technological advancements and improvements to develop advanced treatment options for impotence/erectile dysfunction. The main aim of vendors is to develop a treatment that is faster, more effective with fewer side effects. These advancements in the treatment of ED were observed to expand in the market, and more options are likely to be available in the upcoming years. Several new device technologies for ED treatment are introduced in the market. One of the technologies is the low-intensity shock wave extracorporeal therapy (LI-ESWT), which is a quite promising method in treating erectile dysfunction. This therapy is already proven to be effective in cardiology, in the case of kidney stones, and observed recent success in reversible ischemic tissues of the heart and fractures. The LI-ESWT is a wand-like device placed near different areas of the penis, and it releases acoustic waves, which interact with the tissues and release angiogenic factors leading to improvement of blood circulation.

Key Drivers and Trends fueling Market Growth:

    --  Increasing Strategic Agreements & Collaborations
    --  Increasing in e-Commerce Delivery of ED Drugs & Devices
    --  Increasing Incidence of Erectile Dysfunction and Other Chronic Diseases
    --  Advancements in Erectile Dysfunction Treatment Devices

Erectile Dysfunction Market - Geography

North America dominated the global erectile dysfunction treatment market owing to factors such as better access to both erectile dysfunction prescription and generic drugs, reimbursement coverage for surgeries in ED, better healthcare infrastructure, increasing R&D innovations, and growing demand for ED drugs. The US is the major revenue contributor in the region and accounted for about 92% of the market share. In the US, the ED drugs market is likely to register a negative CAGR owing to the patent expiries of major drugs such as Viagra, Cialis, and Levitra. Pfizer's Viagra experienced around 27% drop in the CAGR growth rate in the past five years. The majority of Viagra's revenue decline was observed in the US, i.e., from $788 million in 2017 to $217 million in 2018. Whereas the revenue of Viagra was found to be increased by 1% outside the US, indicating sustainability of patent protection. However, the ED devices market is growing at a positive rate and is likely to grow at a CAGR of 3.11% in North America.

Get your sample today!

Erectile Dysfunction Market by Geography

    --  North America
        --  US
        --  Canada
    --  Europe
        --  UK
        --  Germany
        --  France
        --  Italy
        --  Spain
    --  APAC
        --  China
        --  India
        --  Japan
        --  South Korea
        --  Australia
    --  Latin America
        --  Mexico
        --  Brazil
        --  Argentina
    --  Middle East & Africa
        --  Saudi Arabia
        --  UAE
        --  South Africa

Major Vendors

    --  Eli Lilly and Company
    --  VIVUS
    --  Pfizer
    --  Bayer
    --  Boston Scientific
    --  Coloplast
    --  Teva Pharmaceuticals
    --  Viatris
    --  Dong-A Socio Holdings

Other Prominent Vendors

    --  Aurobindo Pharma
    --  Dr. Reddy's Laboratories
    --  Cristalia
    --  Metuchen Pharmaceuticals
    --  Menarini Group
    --  SK Chemicals
    --  Seelos Therapeutics
    --  GlaxoSmithKline
    --  Sanofi
    --  Lupin
    --  Cipla
    --  Sandoz
    --  Endo International
    --  Ferring Pharmaceuticals
    --  Alembic Pharmaceuticals
    --  Guangzhou Pharmaceutical Holdings
    --  iX Biopharma
    --  Dornier MedTech
    --  Zephyr Surgical Implants
    --  Augusta Medical Systems
    --  Launch Medical
    --  Bonro Medical
    --  Owen Mumford
    --  Direx Group
    --  Zimmer Medizin Systeme
    --  MTS Medical UG
    --  Medispec
    --  Inceler Medical
    --  NOVAmedtek
    --  WIKKON
    --  Top Quality Group
    --  Promedon
    --  Timm Medical Technologies
    --  Global Life Technologies
    --  Urology Health Store
    --  Hims

Explore our healthcare & lifesciences profile to know more about the industry.

Read some of the top-selling reports:

    --  Premature Ejaculation Therapeutics Market - Global Outlook and Forecast
    --  Sexual Wellness Market - Global Outlook and Forecast 2020-2025
    --  Benign Prostatic Hyperplasia (BPH) Devices Market - Global Outlook and
        Forecast 2020-2025
    --  Ureteral Stents Market - Global Outlook and Forecast 2021-2026

About Arizton:

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.


Call: +1-312-235-2040
+1 302 469 0707

View original content:

SOURCE Arizton Advisory & Intelligence